Better Antigens. Better Antibodies. Better Assays.
SDIX, (Nasdaq: SDIX ) is a biotechnology company with a core expertise in creating better antigens, better antibodies and better assays for the pharmaceutical and biotechnology markets. For over 20 years, SDIX has been a leading immuno-solutions company, developing results-oriented and innovative antibody-based solutions that enable customers to meet high performance research, diagnostic and commercialization objectives.
In the life science market, SDIX’s technology and capabilities are being used to help discover disease mechanisms, facilitate development of new drugs, and provide antibodies and assays for the diagnosis of disease.
Discover who SDIX is.
Watch the video of Fran DiNuzzo, President and CEO.
SDIX is led by a management team of:
Fran DiNuzzo, President and CEO
Bratton, VP of Finance and CFO
The SDIX Board of Directors
Strategic Diagnostics Inc. d/b/a SDIX. Listed on the NASDAQ: SDIX
SDIX is proud to have earned a number of certificates which shows our dedication to having a quality and respected operations.
SDIX's News & Media will help you answer your questions about our latest Press Releases, Product News, Upcoming Events and Publications.
Publications from SDIX authors and about our products and services.
Find out if SDIX will be exhibiting at the shows you'll be attending.
A brief history of SDIX -- from Strategic Diagnostics (SDI) to SDIX.